NexxGen Genomics Presents
AcquGEN Technology
AcquGen
Target Sequencing Technology
AcquGen
Automated Target Sequencer Exclusives
The ACQUGEN ATS is the first of it's kind technology that allows laboratories to diagnose both Advanced Genetic Diagnostics, coupled with lower cost Serology Tests.
This will dramatically reduce costs on staffing, operations, maintenance and improve valuable lab space.
AcquGen Genomic Chip &
Serology Chip
"Helping Doctors, Help Patients"
Molecular Assay Development
With 70 standardized and unique assays, NexxGen Genomics can provide laboratories the ability to diagnose a wide-range of conditions. Because of our expertise in assay development, we also can design assays rapidly, to meet new conditions or diseases that emerge.
Designing a Fully Multiplexing Assay has many challenges. Through our designing process, we have identified techniques to rigorously develop our Multiplexed and Genotyped Assays, with the highest level of accuracy and sensitivity available.
Our science comes first. Accuracy and Sensitivity is paramount with genetic testing. Having a high level of sensitivity with our technology, allows us to perform tests, where sample volumes may be reduced due to early disease state, location of sample extracted or difficulty in sample collection.
Personalized Medicine
Women’s Health
NexxGen Genomics is developing assays for genes associated with hereditary breast and ovarian cancer, among other conditions. The focus areas include:
- HPV Genotyping - High Risk
- Hormones
- Sexual Transmitted Diseases
- Breast Cancer
Oncology
Infectious Disease
Unique & Specialized
NexxGen Genomics is also working on assays for rare genetic disorders and complex conditions, providing much-needed diagnostic tools for these underserved areas. The focus areas include:
- Wound Care: Bacteria, Antibiotic Resistance and Fungus
- Joint Infection: Bacteria, Yeast, Antibiotic Resistance
- Allergy Testing (Serology): IgE, IgM, IgG, Food, Environmental
Schedule A Call
NexxGen Genomics is revolutionizing personalized medicine and targeting key health areas with its innovative molecular assays. By focusing on these critical areas, NexxGen Genomics is poised to make a significant impact on global health outcomes, improving patient diagnosis and treatment across a broad spectrum of diseases and conditions.
To explore more about our technology in an easy-to-understand format, let’s schedule you a call with one of our key stakeholders to further articulate our scientific methods.